The Phantom Limb Pain Treatment Market to grow on an organic note

The Phantom Limb Pain Treatment Market is likely to grow on a robust note in the next decade. The next decade would be seeing the integration of telehealth services with the physical ones that exist at the moment. Urgent care and primary care are bound to be accessed through virtual visits, along with improvement in collaboration with the clinics, dialysis centres, long-term care facilities, and mental health services. This shifting is to be witnessed in the healthcare vertical shortly.

In Carlen’s study, 50% of those patients complaining of pain described it as constant knife jabs or a strong electrical current, 12% felt as though the limb was on fire, and others described sensations such as crushing and bad cramps. Phantom limb pain is estimated to be experienced in 3% to 5% of the amputee population.

Since these patients are usually in extreme distress (some have been known to commit suicide), it is of paramount importance that its mechanism of control be understood and an effective cure be discovered.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/23041

The global market for phantom limb pain treatment can be segmented on basis of treatment, drug class, end users and geography:

Treatment	Neurosurgery Electrical Stimulation Dorsal Column Stimulation Pharmacological Treatment Biofeedback Treatment Psychological Management
Drug Class	Antidepressants (tricyclic) Anticonvulsants Calcitonin NMDA receptor antagonists Local anesthetics Opioids Beta-blockers Serotonin reuptake inhibitors
End Users	Hospitals Ambulatory Surgical Centers Neurological Centers and Research Institutions Emergency Rooms

For the entire list of market players, request for Table of Content here @ https://www.persistencemarketresearch.com/toc/23041

There are three main theories that attempt to describe the mechanism behind S. Weir Mitchells phantom limbs. They are the Central or Gate theory, the Peripheral theory, and the Psychologic theory.Although no medications exist specifically for phantom pain, some drugs designed to treat other conditions have been helpful in relieving nerve pain. However, various treatment options are available for curing PLP.

On the basis of regional presence, the global phantom limb pain treatment market can be segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

North America and Europe are collectively expected to dominate the global phantom limb pain treatment market due to the increasing awareness and inclination of hospitals towards technological advancement of medical treatment and favorable reimbursement.

Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/23041

Pfizer Inc., Johnson & Johnson Consumer Inc., Mylan Pharmaceuticals and Alcaliber S.A., are among the few companies operating in this field.

About us: Persistence Market Research

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com